Biotech The cancer drug designed to let go Gotistobart's new lung-cancer data are striking. Its real test is whether molecular precision can produce a repeatable survival benefit. 14 Sep 2026 5 min read
Biotech This Fly Wiring Map Doesn’t Stop at the Neck A map of nearly 167,000 neurons follows the male fruit fly’s nervous system through its neck. Its real power is helping researchers choose what to test next. 7 Sep 2026 3 min read
Biotech Daraxonrasib Shrinks Lung Tumors. Can It Buy More Time? One RAS inhibitor, different cancers and different standards of proof. A study guide separates lung tumor activity from the randomized pancreatic results. 5 Sep 2026 4 min read
Biotech Hepcludex FDA Approval: What Bulevirtide Changes for Chronic Hepatitis D FDA approval gives chronic hepatitis D a US treatment pathway. The harder question is whether evidence, diagnosis, price and payer access can catch up. 6 Jun 2026 7 min read
Biotech Brain-Computer Interfaces Are Becoming a Human Interface Problem Brain-computer interfaces are no longer only a lab miracle. They are becoming a new human interface layer, and that changes the stakes. 15 May 2026 6 min read
Biotech Personalized CRISPR Needs a Platform The miracle case is not enough. Personalized CRISPR now has to become medicine that can scale. 15 May 2026 7 min read
Biotech IVF Is Becoming More Automated. The Hard Question Is What Reproduction Becomes Next. IVF is becoming more automated and data-driven, but the future of fertility will be shaped as much by access, ethics, and trust as by lab performance. 13 May 2026 7 min read
Biotech Prime Editing in Humans: First Proof, Big Questions Ahead Prime editing has crossed from elegant theory into the clinic, but the hardest questions are still ahead. 24 Aug 2025 4 min read
Biotech Biotech’s Real Frontier Is Not Hype. It Is Programmable Biology Under Constraint. The real biotech story is not that biology has become easy to rewrite. It is that design power is rising faster than delivery, scale, and governance can comfortably absorb. 11 Jul 2025 4 min read
Biotech Personalized Gene Editing for One Baby Is a Breakthrough—And a Stress Test for Medicine A baby’s personalized CRISPR treatment shows what precision medicine can become. It also exposes the manufacturing, regulatory, and access problems medicine has not solved yet. 6 Jul 2025 5 min read
Biotech AlphaGenome: Why AI DNA Models Matter Only If They Survive Biological Reality AlphaGenome is impressive, but the real bottleneck in AI genomics is still biological validation, not model ambition. 25 Jun 2025 4 min read